
    
      Treatment for Acute Myeloid Leukemia（AML） that has not responded to treatment (refractory) or
      has returned after treatment (relapsed) often do not work. Researchers want to see if an
      immunotherapy drug, combined with a less intense chemotherapy, may be able to help.
    
  